Publications

Search Publications
Export 33 results:
Author Title [ Year(Desc)]
Filters: Keyword is Breast Neoplasms  [Clear All Filters]
2021
Kumar S, Nandi A, Singh S, Regulapati R, Li N, Tobias JW, et al. Dll1 quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nat Commun. 2021 ;12(1):432.
Kang Y, Kuperwasser C. Evolving barcodes shed light into evolving metastases. Dev Cell. 2021 ;56(8):1077-1079.
Rabie EM, Zhang SX, Kourouklis AP, A Kilinc N, Simi AK, Radisky DC, et al. Matrix degradation and cell proliferation are coupled to promote invasion and escape from an engineered human breast microtumor. Integr Biol (Camb). 2021 ;13(1):17-29.
Rabie EM, Zhang SX, Dunn CE, Nelson CM. Substratum stiffness signals through integrin-linked kinase and β1-integrin to regulate midbody proteins and abscission during EMT. Mol Biol Cell. 2021 ;32(18):1664-1676.
Esposito M, Fang C, Cook KC, Park N, Wei Y, Spadazzi C, et al. TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nat Cell Biol. 2021 ;23(3):257-267.
Spadazzi C, Mercatali L, Esposito M, Wei Y, Liverani C, De Vita A, et al. Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis. Bone. 2021 ;144:115775.
2022
Shen M, Smith HA, Wei Y, Jiang Y-Z, Zhao S, Wang N, et al. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nat Cancer. 2022 ;3(1):60-74.
Chen H, Zhan M, Liu J, Liu Z, Shen M, Yang F, et al. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction. J Med Chem. 2022 ;65(18):12188-12199.